Auriela Haller

Title: Auriela Haller: Innovator in Vaccine Development

Introduction

Auriela Haller is a prominent inventor based in Redwood City, CA (US). He has made significant contributions to the field of vaccine development, particularly through his innovative work with recombinant viruses. His expertise and dedication to advancing medical science have led to the creation of valuable patents that aim to improve public health.

Latest Patents

Auriela Haller holds a patent for "Recombinant parainfluenza virus expression systems and vaccines." This invention relates to recombinant bovine parainfluenza virus (bPIV) cDNA or RNA, which can be utilized to express heterologous gene products in suitable host cell systems. The technology also facilitates the rescue of negative strand RNA recombinant viruses that express, package, and present the heterologous gene product. The chimeric viruses and expression products developed from this invention can be effectively used in vaccine formulations, including those targeting a wide range of pathogens and antigens. He has 1 patent to his name.

Career Highlights

Auriela Haller is currently associated with Medimmune Vaccines, Inc., where he continues to work on groundbreaking vaccine technologies. His role at the company allows him to collaborate with other experts in the field, further enhancing the impact of his inventions.

Collaborations

One of his notable coworkers is Kathleen L Coelingh. Their collaboration exemplifies the teamwork necessary for advancing vaccine research and development.

Conclusion

Auriela Haller's contributions to vaccine innovation through his patented technologies demonstrate his commitment to improving health outcomes. His work continues to influence the field of immunology and vaccine development.